This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
OKYO Pharma 配当金
配当金 基準チェック /06
主要情報
n/a
配当利回り
n/a
配当性向
| 業界平均利回り | 1.8% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 一株当たり利益 | -UK£0.26 |
| 3年後の配当利回り予想 | n/a |
最近の配当金アップデート
更新なし
Recent updates
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?
Nov 26
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?
Jan 27Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation
Sep 22We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth
Mar 17We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow
Dec 02決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if OKYO's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if OKYO's dividend payments have been increasing.
配当利回り対市場
| OKYO Pharma 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (OKYO) | n/a |
| 市場下位25% (GB) | 2.1% |
| 市場トップ25% (GB) | 5.6% |
| 業界平均 (Biotechs) | 1.8% |
| 3年後のアナリスト予想 (OKYO) | n/a |
注目すべき配当: Unable to evaluate OKYO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate OKYO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as OKYO has not reported any payouts.